BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Equibles//Investor Events//EN CALSCALE:GREGORIAN METHOD:PUBLISH NAME:enGene Therapeutics Inc. (ENGN) investor events X-WR-CALNAME:enGene Therapeutics Inc. (ENGN) investor events DESCRIPTION:Earnings calls and investor events for enGene Therapeutics Inc. (ENGN)\, from Equibles. X-WR-CALDESC:Earnings calls and investor events for enGene Therapeutics Inc . (ENGN)\, from Equibles. REFRESH-INTERVAL;VALUE=DURATION:PT6H X-PUBLISHED-TTL:PT6H BEGIN:VEVENT UID:035a3774-bf52-4718-ae9f-f9b61194a7d4@equibles.com DTSTAMP:20260617T191013Z DTSTART;VALUE=DATE:20251222 DTEND;VALUE=DATE:20251223 SEQUENCE:0 STATUS:CANCELLED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Earnings Call\, FY2025 Q4 DESCRIPTION:No call was held: the company published its results without one . END:VEVENT BEGIN:VEVENT UID:cc1fbb86-83a2-44f1-a8e0-8a50fadd8cfd@equibles.com DTSTAMP:20260916T141406Z DTSTART;VALUE=DATE:20260226 DTEND;VALUE=DATE:20260227 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Conference: Oppenheimer 36th Annual Healthcare Life Sciences Conference DESCRIPTION:Oppenheimer 36th Annual Healthcare Life Sciences Conference\nTh e start time has not been announced.\nWebcast: https://event.summitcast.co m/view/CTtthLh2Bi2D9aYoKpvtEv/guest_book?session_id=Vuvt6T3MqYWsDB5DDstH6n END:VEVENT BEGIN:VEVENT UID:72bb137d-154c-4bb3-af91-a777e52b6dc0@equibles.com DTSTAMP:20260707T163648Z DTSTART;VALUE=DATE:20260309 DTEND;VALUE=DATE:20260310 SEQUENCE:0 STATUS:CANCELLED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Earnings Call\, FY2026 Q1 DESCRIPTION:No call was held: the company published its results without one . END:VEVENT BEGIN:VEVENT UID:b0b339d8-0fe5-4830-af75-90ddf0da9cab@equibles.com DTSTAMP:20260704T215323Z DTSTART;VALUE=DATE:20260309 DTEND;VALUE=DATE:20260310 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Conference: Leerink Partners 2026 G lobal Healthcare Conference DESCRIPTION:Leerink Partners 2026 Global Healthcare Conference\nThe start t ime has not been announced.\nWebcast: https://event.summitcast.com/view/mT 9poctHDNthc6b89WqVjf/guest_book?session_id=HMtxh6oG6h8zGx4WWHFbTV END:VEVENT BEGIN:VEVENT UID:9a82db58-59f1-4623-9360-84784e58732a@equibles.com DTSTAMP:20260704T215323Z DTSTART;VALUE=DATE:20260310 DTEND;VALUE=DATE:20260311 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Conference: Barclays 28th Annual Gl obal Healthcare Conference DESCRIPTION:Barclays 28th Annual Global Healthcare Conference\nThe start ti me has not been announced.\nWebcast: https://event.webcasts.com/starthere. jsp?ei=1753339&tp_key=10741a06bb&tp_special=8 END:VEVENT BEGIN:VEVENT UID:4ab4be28-f394-4cc4-b902-cd4c7f4342b1@equibles.com DTSTAMP:20260704T215323Z DTSTART;VALUE=DATE:20260311 DTEND;VALUE=DATE:20260312 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Conference: Citizens Life Sciences Conference DESCRIPTION:Citizens Life Sciences Conference\nThe start time has not been announced.\nWebcast: https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4A FMd/guest_book?session_id=7npkQzyS756H3kLzCk6Lsq END:VEVENT BEGIN:VEVENT UID:df4db65e-97e9-48fd-8c71-ca70c0d31e2d@equibles.com DTSTAMP:20260615T154134Z DTSTART;VALUE=DATE:20260615 DTEND;VALUE=DATE:20260616 SEQUENCE:0 STATUS:CANCELLED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Earnings Call\, FY2026 Q2 DESCRIPTION:No call was held: the company published its results without one . END:VEVENT BEGIN:VEVENT UID:a0dc9c49-ebb3-4196-bf68-79a29a4de1e1@equibles.com DTSTAMP:20261002T212543Z DTSTART;VALUE=DATE:20260811 DTEND;VALUE=DATE:20260812 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Investor Update: enGene Therapeutic s Virtual KOL Event to Discuss Emerging Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights DESCRIPTION:enGene Therapeutics Virtual KOL Event to Discuss Emerging Non-M uscle Invasive Bladder Cancer (NMIBC) Market Insights\nThe start time has not been announced.\nWebcast: https://lifescievents.com/event/tk32plw/ URL:https://equibles.com/stocks/engn/events/a0dc9c49-ebb3-4196-bf68-79a29a4 de1e1 END:VEVENT BEGIN:VEVENT UID:fbd89c12-b3f9-4902-95a4-d139e30a0ff0@equibles.com DTSTAMP:20260902T042720Z DTSTART;VALUE=DATE:20260908 DTEND;VALUE=DATE:20260909 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Conference: Wells Fargo 21st Annual Healthcare Conference DESCRIPTION:Wells Fargo 21st Annual Healthcare Conference\nThe start time h as not been announced.\nWebcast: https://event.summitcast.com/view/aMepMFx Wv3z5SRZ9meKJzp/guest_book?session_id=YoF6fqgTWXQkRJzW4CHJVs URL:https://equibles.com/stocks/engn/events/fbd89c12-b3f9-4902-95a4-d139e30 a0ff0 END:VEVENT BEGIN:VEVENT UID:6923a004-f290-4212-a11e-c7e3b01699a2@equibles.com DTSTAMP:20260902T042720Z DTSTART;VALUE=DATE:20260914 DTEND;VALUE=DATE:20260915 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Conference: Morgan Stanley 24th Ann ual Global Healthcare Conference DESCRIPTION:Morgan Stanley 24th Annual Global Healthcare Conference\nThe st art time has not been announced.\nWebcast: https://event.webcasts.com/star there.jsp?ei=1773606&tp_key=ae22a07e31&tp_special=8 URL:https://equibles.com/stocks/engn/events/6923a004-f290-4212-a11e-c7e3b01 699a2 END:VEVENT BEGIN:VEVENT UID:66bdf037-09cc-478a-9181-1c236c4e6413@equibles.com DTSTAMP:20260902T042720Z DTSTART;VALUE=DATE:20260915 DTEND;VALUE=DATE:20260916 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Conference: H.C. Wainwright 28th An nual Global Investment Conference DESCRIPTION:H.C. Wainwright 28th Annual Global Investment Conference\nThe s tart time has not been announced.\nWebcast: https://journey.ct.events/view /89c350cd-5c0f-40d1-be14-bb4254a2f5a9 URL:https://equibles.com/stocks/engn/events/66bdf037-09cc-478a-9181-1c236c4 e6413 END:VEVENT BEGIN:VEVENT UID:cf30ef89-c56b-4ab5-b5af-4d750d9cfe39@equibles.com DTSTAMP:20261002T212544Z DTSTART;VALUE=DATE:20261015 DTEND;VALUE=DATE:20261016 SEQUENCE:0 STATUS:CONFIRMED TRANSP:TRANSPARENT SUMMARY:enGene Therapeutics Inc. (ENGN) Investor Update: enGene Therapeutic s Inc. Detalimogene plus Surfactant KOL Webinar DESCRIPTION:enGene Therapeutics Inc. Detalimogene plus Surfactant KOL Webin ar\nThe start time has not been announced.\nWebcast: https://lifescievents .com/event/egjs02p/ URL:https://equibles.com/stocks/engn/events/cf30ef89-c56b-4ab5-b5af-4d750d9 cfe39 END:VEVENT END:VCALENDAR